Señales en vivo de NVRO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 may 2024 @ 16:00):

Stats
Volumen de hoy	843 269
Volumen promedio	491 531
Capitalización de mercado	369.80M
EPS	$0 ( 2024-05-07 )
Próxima fecha de ganancias	( $0 ) 2024-07-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.97
ATR14	$0.0440 (0.43%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Thornal Kevin R	Sell	24 233	Common Stock
2024-04-11	Grossman D Keith	Sell	3 986	Common Stock
2024-04-04	Rashid Kashif	Sell	479	Common Stock
2024-03-31	Kosaraju Sridhar	Buy	1 090	Common Stock
2024-03-31	Demane Michael F	Buy	1 817	Common Stock

INSIDER POWER
60.42
Last 97 transactions
Buy: 980 834 \| Sell: 269 822

Volumen Correlación

Largo: -0.34 (neutral)

Corto: -0.11 (neutral)

Signal:(40.975) Neutral

Nevro Corp Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nevro Corp Correlación - Moneda/Commodity

-0.62
( weak negative )

-0.57
( weak negative )

0.00
( neutral )

-0.59
( weak negative )

-0.13
( neutral )

0.72
( moderate )

Nevro Corp Finanzas

Annual	2023
Ingresos:	$425.17M
Beneficio Bruto:	$278.53M (65.51 %)
EPS:	$-2.56

FY	2023
Ingresos:	$425.17M
Beneficio Bruto:	$278.53M (65.51 %)
EPS:	$-2.56

FY	2022
Ingresos:	$406.37M
Beneficio Bruto:	$276.37M (68.01 %)
EPS:	$0.0850

FY	2021
Ingresos:	$386.91M
Beneficio Bruto:	$266.04M (68.76 %)
EPS:	$-3.77

Financial Reports:

No articles found.

Nevro Corp

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.